首发未服药精神分裂症患者血清同型半胱氨酸水平与临床症状的关系
Relationship between serum homocysteine level and clinical symptoms in first-episode untreated schizophrenia
ES评分 0
| DOI |
| 刊名 |
Journal of International Psychiatry
|
| 年,卷(期) |
2020, 47(5) |
| 作者 |
|
| 作者单位 |
洛阳市第五人民医院 ;
|
| 摘要 |
【摘要】目的:研究分析首发未服药精神分裂症患者血清同型半胱氨酸(Hcy)水平变化与临床症状之间的关系,进一步探讨精神分裂症发展过程中Hcy所发挥的作用,为临床干预提供参考。方法:将本院精神科于2018年06月--2020年06月接收的120例首发未服药精神分裂症患者作为研究主体(研究组),另选取120例正常者作为对照(常规组)。利用PANSS(阴性与阳性症状量表)对精神分裂症患者进行症状评估,利用ELISA(酶联免疫吸附试验)测定所有观察对象Hcy水平并进行对比,进一步探讨Hcy与患者病程、年龄、PANSS量表评分以及BMI指数之间的关系。结果:研究组Hcy高于常规组(p<0.05);Hcy与阴性症状、PANSS总分表现为正性相关(p<0.05)。结论:严重的精神病理症状有可能是导致首发未服药精神分裂症患者Hcy水平过高的主要原因。
|
| Abstract |
[Abstract] Objective: To study the relationship between the changes of serum homocysteine (Hcy) level and clinical symptoms in first-episode untreated schizophrenia, and further explore the role of Hcy in the development of schizophrenia, so as to provide reference for clinical intervention. Methods: 120 first-episode non medication schizophrenic patients in our hospital from June 2018 to June 2020 were selected as the research subjects (Study Group), and another 120 normal subjects were selected as the control group (conventional group). PANSS (negative and positive symptom scale) was used to evaluate the symptoms of schizophrenic patients. ELISA (enzyme-linked immunosorbent assay) was used to measure and compare the Hcy levels of all the subjects. The relationship between Hcy and the course of disease, age, PANSS scale score and BMI index was further explored. Results: Hcy in study group was higher than that in routine group (P < 0.05); Hcy was positively correlated with negative symptoms and PANSS total score (P < 0.05). Conclusion: severe psychopathological symptoms may be the main reason for the high level of Hcy in first-episode untreated schizophrenia.
|
| 基金项目 |
|
| 页码 |
910-912 |
赫利寒*.
首发未服药精神分裂症患者血清同型半胱氨酸水平与临床症状的关系 [J].
国际精神病学杂志.
2020; 47; (5).
910 - 912.